Wedbush Securities’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-16,330
| Closed | -$6K | – | 1140 |
|
|
2023
Q1 | $6K | Sell |
16,330
-1,970
| -11% | -$724 | ﹤0.01% | 1075 |
|
|
2022
Q4 | $16K | Hold |
18,300
| – | – | ﹤0.01% | 1040 |
|
|
2022
Q3 | $29K | Hold |
18,300
| – | – | ﹤0.01% | 1026 |
|
|
2022
Q2 | $37K | Hold |
18,300
| – | – | ﹤0.01% | 1045 |
|
|
2022
Q1 | $43K | Buy |
18,300
+300
| +2% | +$705 | ﹤0.01% | 1081 |
|
|
2021
Q4 | $84K | Buy |
18,000
+2,500
| +16% | +$11.7K | ﹤0.01% | 1138 |
|
|
2021
Q3 | $118K | Buy |
15,500
+3,500
| +29% | +$26.6K | 0.01% | 1119 |
|
|
2021
Q2 | $116K | Buy |
+12,000
| New | +$116K | 0.01% | 1119 |
|
|
2021
Q1 | – | Sell |
-10,700
| Closed | -$73K | – | 1102 |
|
|
2020
Q4 | $73K | Buy |
+10,700
| New | +$73K | 0.01% | 849 |
|